Find clinical trials for Lymphoma in Nashville, TN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Nashville, TN, USA:
This is a Phase 1/2 study of imvotamab in adult subjects with relapsed or refractory B-cell Non-Hodgkin Lymphoma. This study will consist of...
Phase 1, Phase 2
Nashville, Tennessee, United States and 26 other locations
This study is a Phase 1multicenter study with a Dose Escalation and Dose Expansion evaluating safety and efficacy of MT-601 administration to patient...
Phase 1
Nashville, Tennessee, United States and 3 other locations
patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma to determine if ARV-393 may be a possible treatment option.ARV-3...
Phase 1
Nashville, Tennessee, United States and 7 other locations
A Phase 1/2 Study of bbT369, a dual targeting CAR T cell drug product with a gene edit, in Relapsed and/or Refractory B cell Non-Hodgkin's Lymphoma...
Phase 1, Phase 2
Nashville, Tennessee, United States and 3 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Nashville, Tennessee, United States and 66 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Nashville, Tennessee, United States and 215 other locations
purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...
Phase 2
Nashville, Tennessee, United States and 82 other locations
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Nashville, Tennessee, United States and 73 other locations
by the intravenous (IV) route to participants with solid tumors or lymphomas.The main goals of this study are to:Find the recommended dose o...
Phase 1, Phase 2
Nashville, Tennessee, United States and 9 other locations
safety of ibrutinib given in combination with bendamustine and rituximab in patients 65 years of age or older with newly diagnosed mantle cell lymphoma...
Phase 3
Nashville, Tennessee, United States and 203 other locations
Clinical trials
Research sites
Resources
Legal